Verition Fund Management’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.51M Buy
19,181
+17,168
+853% +$4.93M 0.02% 788
2025
Q1
$621K Sell
2,013
-4,050
-67% -$1.25M ﹤0.01% 1865
2024
Q4
$2.14M Buy
+6,063
New +$2.14M 0.01% 1127
2024
Q3
Sell
-2,693
Closed -$858K 2784
2024
Q2
$858K Buy
2,693
+420
+18% +$134K ﹤0.01% 1225
2024
Q1
$522K Sell
2,273
-3,718
-62% -$854K ﹤0.01% 1447
2023
Q4
$1.32M Buy
5,991
+1,512
+34% +$332K 0.01% 806
2023
Q3
$1.01M Sell
4,479
-3,457
-44% -$781K 0.01% 914
2023
Q2
$1.75M Buy
7,936
+6,978
+728% +$1.54M 0.02% 639
2023
Q1
$215K Sell
958
-3,085
-76% -$691K ﹤0.01% 1571
2022
Q4
$1.12M Buy
4,043
+2,217
+121% +$617K 0.02% 722
2022
Q3
$382K Buy
1,826
+603
+49% +$126K ﹤0.01% 1612
2022
Q2
$288K Buy
+1,223
New +$288K 0.01% 1679
2021
Q4
Sell
-1,843
Closed -$340K 2138
2021
Q3
$340K Buy
1,843
+660
+56% +$122K ﹤0.01% 1169
2021
Q2
$212K Buy
+1,183
New +$212K ﹤0.01% 1419
2020
Q3
Sell
-3,534
Closed -$428K 1285
2020
Q2
$428K Buy
+3,534
New +$428K 0.01% 592
2020
Q1
Sell
-4,237
Closed -$373K 955
2019
Q4
$373K Sell
4,237
-2,163
-34% -$190K 0.01% 662
2019
Q3
$510K Buy
6,400
+580
+10% +$46.2K 0.01% 512
2019
Q2
$454K Buy
+5,820
New +$454K 0.01% 613
2016
Q3
Sell
-4,768
Closed -$505K 1221
2016
Q2
$505K Buy
4,768
+1,095
+30% +$116K 0.06% 324
2016
Q1
$409K Sell
3,673
-4,288
-54% -$477K 0.07% 336
2015
Q4
$1.25M Buy
+7,961
New +$1.25M 0.24% 79
2015
Q2
Sell
-3,399
Closed -$586K 697
2015
Q1
$586K Buy
+3,399
New +$586K 0.07% 71
2014
Q4
Sell
-3,854
Closed -$496K 645
2014
Q3
$496K Buy
+3,854
New +$496K 0.07% 220